Rezolute, Inc. (RZLT)

Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day

View Press Release View All

View All Events

Nov 13, 2023 • 4:05pm EST

Rezolute Reports First Quarter Fiscal 2024 Results

Oct 17, 2023 • 8:00am EDT

Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism

Oct 11, 2023 • 8:00am EDT

Rezolute Announces Further Evidence of RZ358’s Efficacy in Tumor-Mediated Hyperinsulinism

Corporate Presentation Q4 2023

View Presentation

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

MENU